Delivery Order SPE2DB20D2104-SPE2DB21FS02T
- Not listed
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmacy Branch in Philadelphia. The contract, valued at $1,768.80, is a Delivery Order awarded by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with Cencora, Inc. (Amerisourcebergen's parent company) worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
- This federal contract award, valued at $86,377.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the DLA's Indefinite Delivery Contract (IDC) for the Prime Vendor Pharmaceutical Branch - Philadelphia, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
- This federal contract award is for a Prime Vendor Pharmaceutical Distribution contract between the U.S. Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,504.19, is a Delivery Order placed under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,666.84, is for a Prime Vendor Pharmaceutical Branch in Philadelphia. It is a delivery order under an Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of a prime vendor pharmaceutical product and supply distribution. The contract, valued at $1,401.62, is a delivery order under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as Amerisourcebergen. The IDC, worth up to $999,999,999.00, serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,484.01, is a delivery order that falls under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen). This IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,532.58, is a delivery order for a "Prime Vendor Pharm Branch-Philadelphia," indicating the supply of pharmaceutical products and medical supplies. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a "Prime Vendor Pharm Branch-Philadelphia" requirement. The $13,838.48 firm-fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award, valued at $15,395.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $75,007.80 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, worth up to $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific Delivery Order falls...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FS02TDelivery Order
This federal contract award, valued at $14,119.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a "Prime Vendor Pharm Branch-Philadelphia" to support military and government medical facilities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by the parent company Cencora, Inc., doing business as Amerisourcebergen, valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care items, to DLA facilities worldwide. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a key vendor supporting the medical needs of the U.S. Department of Defense and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 3/4/21 |